| P2093 | author name string | Nadir Askenasy | |
| P2860 | cites work | Chronic antigen stimulation in vivo induces a distinct population of antigen-specific Foxp3 CD25 regulatory T cells | Q80139449 |
| | From vanilla to 28 flavors: multiple varieties of T regulatory cells | Q80141724 |
| | The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form | Q80257293 |
| | Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice | Q80597353 |
| | CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion | Q81111400 |
| | Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development | Q81180071 |
| | Inducing and expanding regulatory T cell populations by foreign antigen | Q81392563 |
| | CD4+CD25high regulatory T cells in human autoimmune diabetes | Q81428869 |
| | Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle | Q81766038 |
| | Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes | Q82746957 |
| | Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo | Q83059341 |
| | IL-2 production by dendritic cells promotes Foxp3(+) regulatory T-cell expansion in autoimmune-resistant NOD congenic mice | Q83228586 |
| | Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice | Q83879823 |
| | Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells | Q83977704 |
| | CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2 | Q84064861 |
| | Intra-islet proliferation of cytotoxic T lymphocytes contributes to insulitis progression | Q84130770 |
| | Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development | Q84136013 |
| | Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes | Q85492396 |
| | Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice | Q87409683 |
| | FOXP3 controls regulatory T cell function through cooperation with NFAT | Q24298179 |
| | Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction | Q24650734 |
| | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 |
| | Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. | Q24679680 |
| | Insulitis in human type 1 diabetes: a comparison between patients and animal models | Q27023712 |
| | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| | Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 |
| | B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 |
| | Multiple immuno-regulatory defects in type-1 diabetes | Q28344695 |
| | A function for interleukin 2 in Foxp3-expressing regulatory T cells | Q28590646 |
| | Opinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes | Q29393228 |
| | Phenotypic and functional features of human Th17 cells | Q29619323 |
| | Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice | Q30498716 |
| | Early over expression of messenger RNA for multiple genes, including insulin, in the Pancreatic Lymph Nodes of NOD mice is associated with Islet Autoimmunity | Q30874892 |
| | Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse | Q33221766 |
| | At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction | Q33268352 |
| | Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation | Q33490627 |
| | Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice | Q33786819 |
| | Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes | Q33840423 |
| | Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct. | Q33869101 |
| | In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation | Q33927309 |
| | Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion | Q33932451 |
| | Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice | Q33955180 |
| | Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. | Q33977505 |
| | Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice | Q34155881 |
| | CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity | Q34161141 |
| | The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. | Q34452348 |
| | Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice. | Q34488588 |
| | Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes | Q38289295 |
| | Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response | Q34533933 |
| | Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans | Q34534117 |
| | In vivo instruction of suppressor commitment in naive T cells | Q34548023 |
| | Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. | Q34553677 |
| | Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease | Q34693075 |
| | Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases | Q34791870 |
| | IL-21 signaling is critical for the development of type I diabetes in the NOD mouse | Q34823699 |
| | T-cell activation: a multidimensional signaling network. | Q34858190 |
| | Analysis of islet inflammation in human type 1 diabetes. | Q34917032 |
| | Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodes | Q35070682 |
| | The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure | Q35103993 |
| | Beta cell MHC class I is a late requirement for diabetes | Q35143964 |
| | In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro | Q35171080 |
| | Follicular helper T cell signature in type 1 diabetes | Q35242659 |
| | Role of cytokines in the pathogenesis of autoimmune diabetes mellitus | Q35539029 |
| | A single autoimmune T cell receptor recognizes more than a million different peptides | Q35668865 |
| | Central and peripheral autoantigen presentation in immune tolerance | Q35694446 |
| | Integrins and T cell-mediated immunity | Q35698435 |
| | β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure | Q36019335 |
| | Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype | Q36059631 |
| | The NOD mouse: a model of immune dysregulation | Q36072434 |
| | A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. | Q36078042 |
| | Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes | Q36156876 |
| | T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice | Q36356330 |
| | Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes | Q36367942 |
| | T cell regulation as a side effect of homeostasis and competition | Q36370619 |
| | Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice | Q36370868 |
| | Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo | Q36371283 |
| | Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. | Q36371658 |
| | The Strength of Persistent Antigenic Stimulation Modulates Adaptive Tolerance in Peripheral CD4+ T Cells | Q36371739 |
| | Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus | Q36402576 |
| | Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization | Q36402763 |
| | Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen | Q36403106 |
| | Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes | Q36403481 |
| | Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes | Q38333256 |
| | CD4 T cell differentiation in type 1 diabetes. | Q38535279 |
| | Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells? | Q38611317 |
| | Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation | Q38660197 |
| | Cell-mediated immunity in type I (insulin-dependent) diabetes of man and the BB rat. | Q39844178 |
| | Low-affinity major histocompatibility complex-binding peptides in type 1 diabetes. | Q39938664 |
| | Disordered cellular immunity in type 1 diabetes of man and the BB rat | Q40115856 |
| | Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide | Q40418904 |
| | Th1 and Th2 cells in autoimmunity | Q40442396 |
| | Genetic control of autoimmune diabetes in the NOD mouse | Q40444847 |
| | Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. | Q40455088 |
| | Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. | Q40606547 |
| | Ly6C induces clustering of LFA-1 (CD11a/CD18) and is involved in subtype-specific adhesion of CD8 T cells | Q40675952 |
| | Autoimmune diabetes results from genetic defects manifest by antigen presenting cells | Q40845491 |
| | The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells | Q41146074 |
| | Autoimmune diabetes: the role of the islets of Langerhans | Q41203054 |
| | Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. | Q41446869 |
| | Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetes | Q41505445 |
| | Th1-Th2: reliable paradigm or dangerous dogma? | Q41574419 |
| | Multiple TCR V beta usage by infiltrates of young NOD mouse islets of Langerhans. A polymerase chain reaction analysis | Q41637771 |
| | Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells | Q41772561 |
| | Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets | Q41887106 |
| | Complete but curtailed T-cell response to very low-affinity antigen | Q41902378 |
| | T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice | Q41911811 |
| | Impaired negative regulation of homeostatically proliferating T cells | Q42015089 |
| | Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation | Q42499199 |
| | The initial phase of an immune response functions to activate regulatory T cells | Q42571413 |
| | Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool | Q42657755 |
| | Reversal of autoimmunity by boosting memory-like autoregulatory T cells | Q43104323 |
| | The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages | Q43535267 |
| | IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy | Q43577835 |
| | In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes | Q43860764 |
| | Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. | Q44051470 |
| | CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. | Q44132086 |
| | TNF‐α impairs peripheral tolerance towards β‐cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells | Q44429966 |
| | Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation | Q44657813 |
| | Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice | Q44933149 |
| | IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. | Q45951121 |
| | The frequency of high avidity T cells determines the hierarchy of determinant spreading | Q46180161 |
| | Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo | Q46359158 |
| | Functional and molecular comparison of anergic and regulatory T lymphocytes | Q46385458 |
| | Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes | Q46512140 |
| | Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive | Q46920013 |
| | Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. | Q47214393 |
| | TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes | Q47667692 |
| | Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. | Q47726082 |
| | beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct | Q48831166 |
| | Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity. | Q51177622 |
| | Decreased frequencies of CD4+CD25+Foxp3+ cells and the potent CD103+ subset in peripheral lymph nodes correlate with autoimmune disease predisposition in some strains of mice. | Q51460050 |
| | Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. | Q51474938 |
| | Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. | Q51980708 |
| | Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition. | Q52008546 |
| | Immune regulation in type 1 diabetes. | Q52048662 |
| | A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. | Q52064429 |
| | CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. | Q52165458 |
| | Peripheral T cell expansion in lymphopenic mice results in a restricted T cell repertoire. | Q52926771 |
| | Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue | Q36404280 |
| | The control of CD4+CD25+Foxp3+ regulatory T cell survival | Q36501531 |
| | A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop. | Q36666034 |
| | Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice | Q36736666 |
| | Pancreatic islets under attack: cellular and molecular effectors | Q36754684 |
| | Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes | Q36803833 |
| | T-cell promiscuity in autoimmune diabetes | Q36807589 |
| | The vicious cycle of apoptotic beta-cell death in type 1 diabetes | Q36885374 |
| | Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression | Q36915438 |
| | Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse | Q36944568 |
| | Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice | Q36992100 |
| | Autoimmunity since the 1957 clonal selection theory: a little acorn to a large oak. | Q37015268 |
| | The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors | Q37018786 |
| | Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity | Q37100901 |
| | Interleukin-21 is required for the development of type 1 diabetes in NOD mice | Q37163453 |
| | T cell populations in the pancreatic lymph node naturally and consistently expand and contract in NOD mice as disease progresses | Q37174434 |
| | Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. | Q37193763 |
| | Autoimmune mechanisms in type 1 diabetes | Q37215820 |
| | Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression | Q37270469 |
| | Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo | Q37312884 |
| | Feedback control of regulatory T cell homeostasis by dendritic cells in vivo | Q37331528 |
| | Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. | Q37370178 |
| | Regulation of immunity at tissue sites of inflammation | Q37382233 |
| | T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event | Q37389695 |
| | Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. | Q37400735 |
| | Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. | Q37548447 |
| | Checkpoints in the progression of autoimmune disease: lessons from diabetes models | Q37689425 |
| | Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice | Q37704508 |
| | Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease | Q37737987 |
| | Immune cell crosstalk in type 1 diabetes | Q37767586 |
| | Does lymphopenia preclude restoration of immune homeostasis? The particular case of type 1 diabetes | Q37772010 |
| | Pancreatic islet autoimmunity | Q38062696 |
| | Is autoimmune diabetes caused by aberrant immune activity or defective suppression of physiological self-reactivity? | Q38070630 |
| | Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells | Q38174036 |
| | Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells. | Q53234089 |
| | Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. | Q53357495 |
| | Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. | Q53522597 |
| | Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. | Q53560161 |
| | In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. | Q53669552 |
| | CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. | Q53846131 |
| | Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice. | Q53855687 |
| | Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. | Q53859655 |
| | Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. | Q53909275 |
| | Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice. | Q53929277 |
| | Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes. | Q53929870 |
| | Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. | Q54024223 |
| | B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. | Q54120741 |
| | Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. | Q54594961 |
| | Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings | Q58201144 |
| | Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells | Q58234949 |
| | Progression of autoimmune diabetes driven by avidity maturation of a T-cell population | Q58328335 |
| | Increased thymic development of regulatory T cells in NOD mice is functionally dissociated from type I diabetes susceptibility | Q61727549 |
| | Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM | Q63256810 |
| | IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes | Q63325580 |
| | Expression of Ly-6C by T lymphocytes of NOD mice after CD3-complex stimulation. Identification of activated cells during insulitis of prediabetic mice | Q68463912 |
| | Following a diabetogenic T cell from genesis through pathogenesis | Q70488192 |
| | Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis | Q71145935 |
| | The diabetic BB rat. Neither Th1 nor Th2? | Q71542134 |
| | Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus | Q73162675 |
| | Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice | Q73289663 |
| | Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population | Q73740429 |
| | Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation | Q74080415 |
| | Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation | Q74321454 |
| | Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation | Q74371129 |
| | Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells | Q74410084 |
| | Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells | Q74534976 |
| | A defect in central tolerance in NOD mice | Q74825850 |
| | Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse | Q77186394 |
| | Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo | Q77342616 |
| | Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice | Q77488356 |
| | Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 |
| | T-cell compartments of prediabetic NOD mice | Q78830234 |
| | Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development | Q79125427 |
| | Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice | Q79318828 |
| | Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets | Q79609646 |
| | CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive | Q79629254 |
| | Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells | Q79754976 |
| | No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes | Q79843142 |
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 377-388 | |
| P577 | publication date | 2016-01-09 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation | |
| P478 | volume | 147 | |